1. Home
  2. |Insights
  3. |Third Thursday – Employees, Marijuana, and Other Drugs – How Can Employers Respond?

Third Thursday – Employees, Marijuana, and Other Drugs – How Can Employers Respond?

Webinar | 06.22.23, 12:00 PM EDT - 1:00 PM EDT | CLE Offered

Address

Virtual

Register Here

Please join us for the next edition of Third Thursday – Crowell & Moring’s Labor and Employment Update, a webinar series dedicated to helping our clients stay on top of developing law and emerging compliance issues.

Employers, courts, and regulators continue to struggle with how to handle various implications of legalization of marijuana and other drugs, including jurisdictions with laws largely prohibiting employers from conducting drug tests for marijuana or penalizing employees for off-duty marijuana use. These issues are complicated by drug testing obligations imposed on certain employers, particularly government contractors.

In particular, employers are assessing the merits of their existing drug policies and mandatory drug testing programs, especially when weighed against concerns about employee retention and morale. Our webinar will explore the changes in state and local laws and this balance of concerns facing employers. Our panel will discuss risk mitigation strategies and best practices for employers in this area.

Contact: Debbie Feinberg at DFeinberg@crowell.com. 

For more information, please visit these areas: Labor and Employment

Participants

Insights

Webinar | 10.16.25

The Artificial Intelligence Agenda from Capitol Hill to State Capitals: Where We Are and Where We Are (Probably) Going

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:...

View All Insights